| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Mai―17 |
IFIH1 loss of function predisposes to inflammatory and SARS-CoV-2-related infectious diseases |
Rania Najm, Lemis Yavuz, Ruchi Jain, Maha El Naofal, Sathishkumar Ramaswamy, Walid Abuhammour, et al. (+5) Tom Loney, Norbert Nowotny, Alawi Alsheikh-Ali, Ahmad Abou Tayoun, Richard K. Kandasamy |
| 2 |
[GO] |
2024―Apr―08 |
Asymptomatic SARS-CoV-2 infection: A possible role of platelet HLA class I expression level |
Rocco Cantisani, Adriano Spreafico, Giuseppe Marotta |
| 3 |
[GO] |
2023―Dez―11 |
Unveiling the intricacies of COVID-19: Autoimmunity, multi-organ manifestations and the role of autoantibodies |
Zetao Ding, Xingyi Wei, Haoyu Pan, Hui Shi, Yue Shi |
| 4 |
[GO] |
2023―Dez―07 |
To be remembered: B cell memory response against SARS-CoV-2 and its variants in vaccinated and unvaccinated individuals |
Nafees Ahmed, Atharv Athavale, Ankita H. Tripathi, Adarsh Subramaniam, Santosh K. Upadhyay, Anil Kumar Pandey, et al. (+2) Ramesh Chandra Rai, Amit Awasthi |
| 5 |
[GO] |
2023―Nov―13 |
The prize of prizes: mRNA research paving the way for COVID-19 vaccine success wins the Nobel Prize in Physiology or Medicine 2023 |
Marcus Buggert, Petter Höglund |
| 6 |
[GO] |
2023―Jul―26 |
Mild-to-moderate COVID-19 does not predispose to the development of autoimmune rheumatic diseases or autoimmune-based thrombosis |
Paweł Kozłowski, Michalina Lulek, Agata Skwarek, Marcin Śmiarowski, Milena Małecka-Giełdowska, Olga Ciepiela |
| 7 |
[GO] |
2023―Apr―28 |
DNase
analyzed by a novel competitive assay in patients with complications after
ChAdOx1 nCoV
-19 vaccination and in normal unvaccinated blood donors |
Magne Kristoffer Fagerhol, Nina Haagenrud Schultz, Mohammad Reza Mirlashari, Markus Karl Hermann Wiedmann, Lise Sofie Haug Nissen-Meyer, Arne Vasli Lund Søraas, Geir Hetland |
| 8 |
[GO] |
2023―Apr―12 |
Evaluation of Humoral Immune Response After
ChAdOx1 nCoV
-19 Vaccination among Health Care Workers |
Myeong Hee Kim, So Young Kang, Woo In Lee, Min Young Lee |
| 9 |
[GO] |
2022―Dez―22 |
Rational harm-benefit assessments by age group are required for continued COVID-19 vaccination |
Panagis Polykretis, Peter A. McCullough |
| 10 |
[GO] |
2022―Nov―28 |
Potential role of
AIM2
inflammasome in
SARS-CoV
-2 infection |
EE Uresti-Rivera, MH García-Hernández |
| 11 |
[GO] |
2022―Sep―08 |
Impact of monocyte related modulators and kidney function on mortality in hospitalized patients with Covid-19 |
Senka Sendic, Ladan Mansouri, Sebastian Havervall, Charlotte Thålin, Joachim Lundahl, Stefan H Jacobson |
| 12 |
[GO] |
2022―Mrz―17 |
The role of the antigen presentation process in the immunization mechanism of the genetic vaccines against COVID-19 and the need for biodistribution evaluations |
P. Polykretis |
| 13 |
[GO] |
2022―Mrz―04 |
Do reduced numbers of plasmacytoid dendritic cells contribute to the aggressive clinical course of COVID-19 in chronic lymphocytic leukemia? |
C. I. Edvard Smith, Rula Zain, Anders Österborg, Marzia Palma, Marcus Buggert, Peter Bergman, Yenan Bryceson |
| 14 |
[GO] |
2022―Mrz―04 |
Improved immunologic response to COVID-19 vaccine with prolonged dosing interval in hemodialysis patients |
Mathias Haarhaus, Monica Duhanes, Nataša Leševic, Bogdan Matei, Bernd Ramsauer, Rui Da Silva Rodrigues, et al. (+4) Jun Su, Michael Haase, Carla Santos- Araújo, Fernando Macario |
| 15 |
[GO] |
2022―Feb―25 |
SARS-CoV-2 (COVID-19)-specific T-cell and B-cell responses in convalescent rheumatoid arthritis: monozygotic twins pair case observation |
Lucas C M Arruda, Ahmed Gaballa, Rui Da Silva Rodrigues, Bartek Makower, Michael Uhlin |
| 16 |
[GO] |
2021―Dez―28 |
Chagas Disease, COVID-19 and P2X7 Receptor |
Caroline de Souza Ferreira Pereira, Robson Xavier Faria |
| 17 |
[GO] |
2021―Dez―22 |
COVID-19 Immunopathology with emphasis on Th17 response and Cell-based Immunomodulation Therapy: Potential Targets and Challenges |
Arash Pourgholaminejad, Saghar Pahlavanneshan, Mohsen Basiri |
| 18 |
[GO] |
2021―Dez―03 |
High CD4-to-CD8 ratio identifies an at-risk population susceptible to lethal COVID-19 |
Marco De Zuani, Petra Lazničková, Veronika Tomašková, Martina Dvončová, Giancarlo Forte, Gorazd Bernard Stokin, et al. (+3) Vladimir Šrámek, Martin Helán, Jan Frič |
| 19 |
[GO] |
2021―Okt―28 |
Comments on the Discussion Forum: Oromucosal immunomodulation as clinical spectrum mitigating factor in SARS-CoV-2 infection |
Michael L. Smith, Sujata Sharma, Tej P. Singh |
| 20 |
[GO] |
2021―Okt―09 |
Correlation of myeloid-derived suppressor cells with C-reactive protein, ferritin and lactate dehydrogenase levels in patients with severe COVID-19 |
Ayca Emsen, Sua Sumer, Baykal Tulek, Hilal Cizmecioglu, Mevlut Hakan Goktepe, Fikret Kanat, et al. (+3) Yavuz Koksal, Ugur Arslan, Hasibe Artac |
| 21 |
[GO] |
2021―Sep―12 |
Perforin, Covid-19 and a possible pathogenic auto-inflammatory feedback loop |
Louise Cunningham, Ian Kimber, David Basketter, Peter Simmonds, Sheila McSweeney, Christos Tziotzios, John P McFadden |
| 22 |
[GO] |
2021―Sep―12 |
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of Coronavirus 2019 disease |
Maria Giovanna Danieli, Mario Andrea Piga, Alberto Paladini, Eleonora Longhi, Cristina Mezzanotte, Gianluca Moroncini, Yehuda Shoenfeld |
| 23 |
[GO] |
2021―Sep―02 |
Analysis of SARS-CoV-2 Haplotypes and Genomic Sequences during 2020 in Victoria, Australia in the Context of Putative Deficits in Innate Immune Deaminase Anti-Viral Responses |
Robyn A. Lindley, Edward J. Steele |
| 24 |
[GO] |
2021―Sep―01 |
Systemic Inflammation in COVID-19 Patients May Induce Various Types of Venous and Arterial Thrombosis: A Systematic Review |
Sara Tomerak, Safah Khan, Muna Almasri, Rawan Hussein, Ali Abdelati, Ahmed Aly, et al. (+5) Mohammad Salameh, Arwa Saed Aldien, Hiba Naveed, Mohamed B. Elshazly, Dalia Zakaria |
| 25 |
[GO] |
2021―Jun―09 |
Advances in Neutralization Assays for SARS-CoV-2 |
Yuying Lu, Jin Wang, Qianlin Li, Huan Hu, Jiahai Lu, Zeliang Chen |
| 26 |
[GO] |
2021―Mai―31 |
Decreased neutrophil-mediated bacterial killing in COVID-19 patients |
Masoumeh Nomani, Mohammad Varahram, Payam Tabarsi, Seyed MohamadReza Hashemian, Hamidreza Jamaati, Majid Malekmohammad, et al. (+3) Mona Ghazi, Ian M. Adcock, Esmaeil Mortaz |
| 27 |
[GO] |
2021―Apr―19 |
Interactions between SARS coronavirus 2 papain-like protease and immune system: a potential drug target for the treatment of COVID-19 |
Shahab Mahmoudvand, Somayeh Shokri |
| 28 |
[GO] |
2021―Mrz―30 |
Coronavirus infection. an immunologists' perspective |
Juan Bautista De Sanctis, Alexis Hipólito García, Dolores Moreno, Marián Hajduch |
| 29 |
[GO] |
2021―Mrz―12 |
COVID-19: Risk Factors Associated with Infectivity and Severity |
Nahla Fadl, Esraa Ali, Tamer Z. Salem |
| 30 |
[GO] |
2021―Feb―03 |
Early humoral defense: Contributing to confining Covid-19 to conducting airways? |
Carl Persson |
| 31 |
[GO] |
2021―Jan―23 |
An increase in CD62L
dim
neutrophils precedes the development of pulmonary embolisms in COVID-19 patients |
Roy Spijkerman, Nikita KN Jorritsma, Suzanne H Bongers, Bas JJ Bindels, Bernard N Jukema, Lillian Hesselink, et al. (+46) Falco Hietbrink, Luke PH Leenen, Harriët MR van Goor, N. Vrisekoop, Karin AH Kaasjager, Leo Koenderman, Thomas MP Nijdam, Nils LM van de Ven, Remi Verhaegh, Judith S Spanjaard, Benjamin W Verboeket, Duco Laane, Karlijn van Wessem, Daan EJ van spengler, Wiebe Buitenwerf, Giulio Giustarini, Eva Mulder, Harry Heijerman, Amely Daza Zabaleta, Frederique van den bos, Feike Stiphout, Emma Rademaker, Meri RJ Varkila, Nikki de Mul, Olaf L Cremer, Arjen Slooter, Eveline M Delemarre, Stefan Nierkens, Maarten Limper, Femke van Wijk, Aridaman Pandit, Helen Leavis, Chantal C Clark, Arjan D Barendrecht, Cor W Seinen, Sandra Drost-Verhoef, Simone Smits, Naomi M J Parr, Sylvie A E Sebastian, Arnold C Koekman, Annet C van Wesel, Erhard van der Vries, Coen Maas, Steven de Maat, Saskia Haitjema, Imo E Hoefer |
| 32 |
[GO] |
2020―Dez―29 |
Talk of the town in 2021: Covid-19 vaccines likely take centre stage |
Petter Höglund |
| 33 |
[GO] |
2020―Nov―26 |
Covid-19, SSI 50 years and Nobel: Three immunological reasons to remember 2020 |
Petter Höglund, Hans-Gustaf Ljunggren, Roland Jonsson |
| 34 |
[GO] |
2020―Nov―15 |
Coronavirus Disease 2019 (COVID-19): An Overview of the Immunopathology, Serological Diagnosis and Management |
Abubakar Umar Anka, Mohammed Ibrahim Tahir, Sharafudeen Dahiru Abubakar, Mohamed Alsabbagh, Zeineb Zian, Haleh Hamedifar, et al. (+2) Araz Sabzevari, Gholamreza Azizi |
| 35 |
[GO] |
2020―Nov―15 |
Gastrointestinal and Renal Complications in SARS-CoV-2-Infected Patients: Role of Immune System |
Fatemeh Maghool, Ali Valiani, Tahereh Safari, Mohammad Hassan Emami, Samane Mohammadzadeh |
| 36 |
[GO] |
2020―Okt―28 |
T-cell immunobiology and cytokine storm of COVID-19 |
Xiao-Hua Luo, Yan Zhu, Jian Mao, Rui-Chan Du |
| 37 |
[GO] |
2020―Sep―29 |
The cytokine storm - An appropriate, over-reactive response to SARS-COV-2 or the wrong immune pathway? |
Donald Bellgrau, Jaime F. Modiano |
| 38 |
[GO] |
2020―Sep―18 |
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel |
Cecilia Napodano, Krizia Pocino, Annunziata Stefanile, Mariapaola Marino, Luca Miele, Francesca Gulli, et al. (+5) Valerio Basile, Franco Pandolfi, Antonio Gasbarrini, Gian Ludovico Rapaccini, Umberto Basile |
| 39 |
[GO] |
2020―Sep―06 |
Oromucosal immunomodulation as clinical spectrum mitigating factor in SARS-CoV-2 infection. |
Francisco Rodríguez, María Alba-Domínguez, Elena Ortíz, Ángel Ortega |
| 40 |
[GO] |
2020―Sep―02 |
Lymphopenia an important immunological abnormality in patients with COVID-19: Possible mechanisms |
Abdollah Jafarzadeh, Sara Jafarzadeh, Parvin Nozari, Pejman Mokhtari, Maryam Nemati |
| 41 |
[GO] |
2020―Sep―02 |
SARS-CoV-2 And Trojan Horse Phenomenon -Caveat In Vaccine Quest? |
Mehak Singh, Manoj Pawar, Apoorv Tiwari, Atul Bothra, Anshu Maheswari, Pankaj Adhicari |
| 42 |
[GO] |
2020―Aug―15 |
The potential involvement of P2X7 receptor in COVID-19 pathogenesis: a new therapeutic target? |
Paulo A F Pacheco, Robson X Faria |
| 43 |
[GO] |
2020―Jul―22 |
Interferon: the invisible link between COVID-19 and BCGitis female protection? |
Stefano Di Bella, Paolo Cabas, Roberta Maria Antonello, Michele Rizzo |
| 44 |
[GO] |
2020―Jul―22 |
The effect of BCG vaccine in the era of COVID-19 pandemic |
Ahmed M. Abbas, Asmaa AbouBakr, Nermeen Bahaa, Sherry Michael, Marco Ghobrial, Mai E. AbuElmagd, et al. (+3) Omar A. Ahmed, Radwa A. AbdelWahab, Asmaa S. Shaltout |
| 45 |
[GO] |
2020―Jul―22 |
¿Are Superantigens the Cause of Cytokine Storm and viral sepsis in Severe COVID-19? Observations and hypothesis |
Valeria Scaglioni, Enrique R. Soriano |
| 46 |
[GO] |
2020―Jul―13 |
Can medicinal mushrooms have prophylactic or therapeutic effect against COVID-19 and its pneumonic superinfection and complicating inflammation? |
Geir Hetland, Egil Johnson, Soosaipillai V. Bernardshaw, Bjørn Grinde |
| 47 |
[GO] |
2020―Jun―16 |
COVID-19 and maternal pre-eclampsia; a synopsis |
Ahmed M. Abbas, Omar A. Ahmed, Asmaa S. Shaltout |
| 48 |
[GO] |
2020―Mai―23 |
SARS-CoV-2 infection-induced immune responses: friends or foes? |
Keying Li, Zhenhua Hao, Xiaohui Zhao, Jiying Du, Yanlin Zhou |
